• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IFCC 工作组关于评估等效性的建议 第 3 部分:使用参考物质的校准有效性。

IFCC Working Group Recommendations for Assessing Commutability Part 3: Using the Calibration Effectiveness of a Reference Material.

机构信息

Beckman Coulter, Chaska, MN.

Queen Beatrix Hospital, Winterswijk, the Netherlands.

出版信息

Clin Chem. 2018 Mar;64(3):465-474. doi: 10.1373/clinchem.2017.277558. Epub 2018 Jan 18.

DOI:10.1373/clinchem.2017.277558
PMID:29348164
Abstract

A process is described to assess the commutability of a reference material (RM) intended for use as a calibrator based on its ability to fulfill its intended use in a calibration traceability scheme to produce equivalent clinical sample (CS) results among different measurement procedures (MPs) for the same measurand. Three sources of systematic error are elucidated in the context of creating the calibration model for translating MP signals to measurand amounts: calibration fit, calibrator level trueness, and commutability. An example set of 40 CS results from 7 MPs is used to illustrate estimation of bias and variability for each MP. The candidate RM is then used to recalibrate each MP, and its effectiveness in reducing the systematic error among the MPs within an acceptable level of equivalence based on medical requirements confirms its commutability for those MPs. The RM is declared noncommutable for MPs for which, after recalibration, the CS results do not agree with those from other MPs. When a lack of agreement is found, other potential causes, including lack of calibration fit, should be investigated before concluding the RM is noncommutable. The RM is considered fit for purpose for those MPs where commutability is demonstrated.

摘要

描述了一种评估参考物质(RM)适用性的方法,该 RM 旨在用作校准品,其依据是它在校准可溯源性方案中履行其预期用途的能力,以在不同测量程序(MPs)中产生相同测定物的等效临床样本(CS)结果。在创建将 MP 信号转换为测定物量的校准模型时,阐明了系统性误差的三个来源:校准拟合、校准品水平准确性和互换性。使用一组来自 7 个 MPs 的 40 个 CS 结果的示例集,说明了每个 MPs 的偏差和可变性的估计。然后,使用候选 RM 重新校准每个 MPs,并根据医学要求在可接受的等效性水平内确定其在 MPs 之间减少系统性误差的有效性,以确认其对这些 MPs 的互换性。对于那些经过重新校准后 CS 结果与其他 MPs 不一致的 MPs,宣布 RM 不可互换。当发现不一致时,在得出 RM 不可互换的结论之前,应调查其他潜在原因,包括校准拟合不足。对于证明具有互换性的 MPs,RM 被认为是适合用途的。

相似文献

1
IFCC Working Group Recommendations for Assessing Commutability Part 3: Using the Calibration Effectiveness of a Reference Material.IFCC 工作组关于评估等效性的建议 第 3 部分:使用参考物质的校准有效性。
Clin Chem. 2018 Mar;64(3):465-474. doi: 10.1373/clinchem.2017.277558. Epub 2018 Jan 18.
2
IFCC Working Group Recommendations for Assessing Commutability Part 2: Using the Difference in Bias between a Reference Material and Clinical Samples.IFCC 工作组关于评估可比性的建议 第 2 部分:使用参考物质和临床样本之间的偏倚差异。
Clin Chem. 2018 Mar;64(3):455-464. doi: 10.1373/clinchem.2017.277541. Epub 2018 Jan 18.
3
IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design.国际临床化学联合会工作组关于评估可比性的建议 第 1 部分:一般实验设计。
Clin Chem. 2018 Mar;64(3):447-454. doi: 10.1373/clinchem.2017.277525. Epub 2018 Jan 18.
4
The evolving role of commutability in metrological traceability.互换性在计量溯源性中不断演变的作用。
Clin Chim Acta. 2021 Mar;514:84-89. doi: 10.1016/j.cca.2020.12.021. Epub 2021 Jan 5.
5
IFCC Working Group Recommendations for Correction of Bias Caused by Noncommutability of a Certified Reference Material Used in the Calibration Hierarchy of an End-User Measurement Procedure.国际临床化学联合会工作组关于校正因在用户测量程序校准层级中使用的认证参考物质不互换性而导致的偏差的建议。
Clin Chem. 2020 Jun 1;66(6):769-778. doi: 10.1093/clinchem/hvaa048.
6
Assessment of WHO 07/202 reference material and human serum pools for commutability and for the potential to reduce variability among soluble transferrin receptor assays.评估世卫组织 07/202 参考物质和人血清标准品的互换性以及降低可溶性转铁蛋白受体检测方法之间变异性的潜力。
Clin Chem Lab Med. 2023 Apr 18;61(10):1719-1729. doi: 10.1515/cclm-2022-1198. Print 2023 Sep 26.
7
Harmonization and Standardization: Where Are We Now?协调与标准化:我们现在在哪里?
J Appl Lab Med. 2021 Mar 1;6(2):510-521. doi: 10.1093/jalm/jfaa189.
8
Commutability of reference and control materials: an essential factor for assuring the quality of measurements in Laboratory Medicine.参考物质和控制材料的互换性:确保检验医学测量质量的必要因素。
Clin Chem Lab Med. 2019 Jun 26;57(7):967-973. doi: 10.1515/cclm-2019-0154.
9
Commutability Assessment of Candidate Reference Materials for Pancreatic α-Amylase.用于胰腺α-淀粉酶候选参考物质的可比性评估。
Clin Chem. 2018 Aug;64(8):1193-1202. doi: 10.1373/clinchem.2018.289744. Epub 2018 Jun 14.
10
Interassay calibration as a major contribution to the comparability of results in clinical enzymology.
Clin Biochem. 1998 Aug;31(6):489-94. doi: 10.1016/s0009-9120(98)00038-1.

引用本文的文献

1
Development of commutable stabilizing control materials to improve external quality assessment of hemoglobin assay.可互换稳定对照材料的研制,以改善血红蛋白检测的室间质量评价。
Anal Bioanal Chem. 2025 Sep;417(22):5001-5017. doi: 10.1007/s00216-025-06018-4. Epub 2025 Jul 30.
2
Commutability evaluation of glycated albumin candidate EQA materials.糖化白蛋白候选EQA材料的互换性评估。
Clin Chem Lab Med. 2025 May 28. doi: 10.1515/cclm-2025-0507.
3
Antiphospholipid IgG Certified Reference Material ERM-DA477/IFCC: a tool for aPL harmonization?
抗磷脂IgG认证参考物质ERM-DA477/IFCC:用于抗磷脂抗体标准化的工具?
Clin Chem Lab Med. 2025 Mar 21;63(7):1315-1326. doi: 10.1515/cclm-2025-0032. Print 2025 Jun 26.
4
Commutability assessment of new standard reference materials (SRMs) for determining serum total 25-hydroxyvitamin D using ligand binding and liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays.使用配体结合法和液相色谱-串联质谱法(LC-MS/MS)测定血清总25-羟基维生素D的新型标准参考物质(SRM)的互通性评估。
Anal Bioanal Chem. 2025 May;417(12):2539-2561. doi: 10.1007/s00216-024-05699-7. Epub 2025 Jan 10.
5
Behind the scenes of EQA - characteristics, capabilities, benefits and assets of external quality assessment (EQA).EQA幕后 - 外部质量评估(EQA)的特点、能力、益处和优势
Clin Chem Lab Med. 2025 Jan 6;63(5):868-878. doi: 10.1515/cclm-2024-1291. Print 2025 Apr 28.
6
Quantification of Difference in Nonselectivity Between In Vitro Diagnostic Medical Devices.体外诊断医疗器械非选择性差异的量化
Biom J. 2025 Feb;67(1):e70032. doi: 10.1002/bimj.70032.
7
Recommendations for assessing commutability of a replacement batch of a secondary calibrator certified reference material.关于评估二级校准物认证参考物质替代批次互换性的建议。
Clin Chim Acta. 2025 Feb 1;567:120097. doi: 10.1016/j.cca.2024.120097. Epub 2024 Dec 16.
8
Bias in Laboratory Medicine: The Dark Side of the Moon.实验室医学中的偏倚:月亮的暗面。
Ann Lab Med. 2024 Jan 1;44(1):6-20. doi: 10.3343/alm.2024.44.1.6. Epub 2023 Sep 4.
9
Accurate method for value assignment of carcinoembryonic antigen reference materials.癌胚抗原参考物质赋值的准确方法。
J Clin Lab Anal. 2023 Jun;37(11-12):e24936. doi: 10.1002/jcla.24936. Epub 2023 Jul 3.
10
Impact of implementing a category 1 external quality assurance scheme for monitoring harmonization of clinical laboratories in Spain.实施1类外部质量保证计划对西班牙临床实验室监测协调的影响。
Adv Lab Med. 2020 Mar 19;1(1):20200008. doi: 10.1515/almed-2020-0008. eCollection 2020 Mar.